Integral Health Asset Management, LLC Crispr Therapeutics Ag Transaction History
Integral Health Asset Management, LLC
- $859 Million
- Q1 2025
A detailed history of Integral Health Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 150,000 shares of CRSP stock, worth $9.56 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$9.56 Million% of portfolio
0.59%Shares
8 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
63.9MCall Options Held
2.16MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$648 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$387 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$242 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$177 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$162 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....